Literature DB >> 6695663

Repeat treadmill exercise testing: variability of results in patients with angina pectoris.

M R Starling, M Moody, M H Crawford, B Levi, R A O'Rourke.   

Abstract

To assess the reproducibility and individual variability of ECG treadmill exercise test results, we evaluated 23 patients with coronary artery disease and stable exertional angina by means of two control exercise tests performed on different days within a 1 week period. In addition, each control test was followed on the same day by a single dose of placebo or active agent determined in a randomized double-blind manner and the exercise test was repeated. When the mean exercise test results from the control tests on days 1 and 2 were compared, there was a significant increase in exercise duration to angina (7.4 +/- 3.2 to 9.0 +/- 3.3 minutes, p less than 0.05), ST segment depression (7.8 +/- 3.9 to 9.6 +/- 3.6 minutes, p less than 0.01), and maximal exercise (9.7 +/- 3.7 to 11.0 +/- 4.1 minutes, p less than 0.01). In addition, when the mean exercise results on the control test were compared to those on the postplacebo test on the same day, similar increases in exercise duration were observed at each end point (p less than 0.01). Individual differences of more than 2 minutes in exercise duration between the two control tests and between the control and postplacebo tests in time to angina, ST segment depression, and maximal exercise were frequent (26% to 33% of patients). However, the mean rate-pressure products on the two control tests performed on days 1 and 2 and on the control and postplacebo tests performed on the same day did not differ at angina, ST segment depression, and maximal exercise.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695663     DOI: 10.1016/0002-8703(84)90378-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.

Authors:  D P Nicholls; K Moles; D N Gleadhill; K Booth; J Rowan; P Morton
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

2.  Observations on the warm up phenomenon in angina pectoris.

Authors:  M Joy; A W Cairns; D Sprigings
Journal:  Br Heart J       Date:  1987-08

Review 3.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

4.  Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.

Authors:  N Rehnqvist; G Olsson; J Engvall; U Rosenqvist; G Nyberg; A Aberg; G Ulvenstam; A Uusitalo; O Keyriläinen; R Härkönen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Effects of carbon monoxide on myocardial ischemia.

Authors:  E N Allred; E R Bleecker; B R Chaitman; T E Dahms; S O Gottlieb; J D Hackney; M Pagano; R H Selvester; S M Walden; J Warren
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

6.  Effects of Exercise Type on Hemodynamic Responses and Cardiac Events in ACS Patients.

Authors:  Chul Kim; Chul-Hyun Kim; Haemi Jee; Young-Joon Lim; Young-Joo Kim
Journal:  J Phys Ther Sci       Date:  2014-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.